Page last updated: 2024-10-26

donepezil and Anoxia, Brain

donepezil has been researched along with Anoxia, Brain in 2 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riepe, MW1
Dimitrova, DS1
Getova-Spassova, DP1

Reviews

1 review available for donepezil and Anoxia, Brain

ArticleYear
Cholinergic treatment: what are the early neuropathological targets?
    European journal of neurology, 2005, Volume: 12 Suppl 3

    Topics: Aged; Alzheimer Disease; Brain; Cholinergic Agents; Cholinesterase Inhibitors; Dementia; Donepezil;

2005

Other Studies

1 other study available for donepezil and Anoxia, Brain

ArticleYear
Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.
    Journal of pharmacological sciences, 2006, Volume: 101, Issue:3

    Topics: Animals; Avoidance Learning; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Resp

2006